Baidu
map

METAB SYNDR RELAT D:研究发现2型糖尿病中肠道发挥着重要作用!

2017-08-04 佚名 来宝网

由于暴饮暴食,血糖过高,胰腺β细胞功能受损,以及胰岛素调节激素水平不平衡等,在其导致并持续的2型糖尿病的破坏性循环中,肠道似乎发挥着关键作用。文章“肠道:2型糖尿病发病机制的关键”中研究人员调查研究了胃排空率对进食后血糖水平和葡萄糖相关激素释放的影响。发表在杂志《代谢综合征和相关疾病》上。

由于暴饮暴食,血糖过高,胰腺β细胞功能受损,以及胰岛素调节激素水平不平衡等,在其导致并持续的2型糖尿病的破坏性循环中,肠道似乎发挥着关键作用。文章“肠道:2型糖尿病发病机制的关键”中研究人员调查研究了胃排空率对进食后血糖水平和葡萄糖相关激素释放的影响。发表在杂志《代谢综合征和相关疾病》上。

丹麦哥本哈根大学的Jens Juul Holst,Jens Pedersen,Nicolai Jacob Wewer Albrechtsen和Filip Krag Knop的相关的着作专门研究了胃肠道如何有助于调节餐后血浆葡萄糖和分泌称为GIP和GLP的肠降血糖素激素-1。饭后,这些激素有助于诱导和调节释放胰岛素的细胞即胰腺β细胞,以控制血液中的葡萄糖水平。研究人员还讨论了肠道在2型糖尿病患者胰高血糖素分泌过多中的作用。

杂志《代谢综合征和相关疾病》主编及梅奥诊所医学院,罗切斯特,明尼苏达州FRCP(Edin。)医学教授,医学博士Adrian Vella说:“胃肠道调节葡萄糖摄入反应的作用常常被忽视,在这篇评论中,霍尔斯特教授及其同事重新审视了胃肠道在健康和疾病中的作用。”

原始出处:
Holst Jens Juul, Pedersen Jens, Wewer Albrechtsen Nicolai Jacob,et al, The Gut: A Key to the Pathogenesis of Type 2 Diabetes, Metabolic Syndrome and Related Disorders (2017). DOI: 10.1089/met.2017.0015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1887706, encodeId=151f188e706fe, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue Sep 26 17:38:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896126, encodeId=923e1896126b9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu May 24 22:38:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023485, encodeId=f745202348531, content=<a href='/topic/show?id=57ce9605ef6' target=_blank style='color:#2F92EE;'>#重要作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96057, encryptionId=57ce9605ef6, topicName=重要作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 01 17:38:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753251, encodeId=1cd41e5325185, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Apr 26 07:38:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229940, encodeId=237522994073, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Aug 04 10:51:54 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
    2017-09-26 guojianrong
  2. [GetPortalCommentsPageByObjectIdResponse(id=1887706, encodeId=151f188e706fe, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue Sep 26 17:38:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896126, encodeId=923e1896126b9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu May 24 22:38:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023485, encodeId=f745202348531, content=<a href='/topic/show?id=57ce9605ef6' target=_blank style='color:#2F92EE;'>#重要作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96057, encryptionId=57ce9605ef6, topicName=重要作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 01 17:38:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753251, encodeId=1cd41e5325185, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Apr 26 07:38:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229940, encodeId=237522994073, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Aug 04 10:51:54 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
    2018-05-24 一闲
  3. [GetPortalCommentsPageByObjectIdResponse(id=1887706, encodeId=151f188e706fe, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue Sep 26 17:38:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896126, encodeId=923e1896126b9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu May 24 22:38:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023485, encodeId=f745202348531, content=<a href='/topic/show?id=57ce9605ef6' target=_blank style='color:#2F92EE;'>#重要作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96057, encryptionId=57ce9605ef6, topicName=重要作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 01 17:38:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753251, encodeId=1cd41e5325185, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Apr 26 07:38:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229940, encodeId=237522994073, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Aug 04 10:51:54 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1887706, encodeId=151f188e706fe, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue Sep 26 17:38:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896126, encodeId=923e1896126b9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu May 24 22:38:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023485, encodeId=f745202348531, content=<a href='/topic/show?id=57ce9605ef6' target=_blank style='color:#2F92EE;'>#重要作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96057, encryptionId=57ce9605ef6, topicName=重要作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 01 17:38:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753251, encodeId=1cd41e5325185, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Apr 26 07:38:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229940, encodeId=237522994073, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Aug 04 10:51:54 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1887706, encodeId=151f188e706fe, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue Sep 26 17:38:00 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896126, encodeId=923e1896126b9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Thu May 24 22:38:00 CST 2018, time=2018-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2023485, encodeId=f745202348531, content=<a href='/topic/show?id=57ce9605ef6' target=_blank style='color:#2F92EE;'>#重要作用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96057, encryptionId=57ce9605ef6, topicName=重要作用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Thu Mar 01 17:38:00 CST 2018, time=2018-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753251, encodeId=1cd41e5325185, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Thu Apr 26 07:38:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=229940, encodeId=237522994073, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Aug 04 10:51:54 CST 2017, time=2017-08-04, status=1, ipAttribution=)]
    2017-08-04 Y—xianghai

    学习了新知识

    0

相关资讯

Lancet diabetes endo:钠-葡萄糖共转运体抑制剂与其他降糖药物治疗2型糖尿病患者时心血管意外的发生率和死亡率对比。

研究表明钠-葡萄糖共转运体-2(SGLT2)抑制剂empagliflozin(依帕列净)和canagliflozin(卡格列净)可降低心血管意外高风险的2型糖尿病患者心血管意外的发生率和死亡率。在广泛有心血管意外风险的人群中,SGLT2抑制剂的新使用患者和其他降糖药的新使用患者心血管意外的发生率和死亡率是否存在差异?

Clin Cosmet Investig Dent:牙周非手术治疗有益于糖尿病患者血糖的控制

尽管已有多个研究,但是关于牙周治疗对糖尿病的影响仍然存在争议。本研究旨在评估并比较伴有牙周炎的2型糖尿病患者接受或不接受牙周非手术治疗后其血糖控制和牙周状况。研究共纳入了82名符合入选标准的伴有中重度牙周炎的糖尿病患者。随机分为试验组和对照组。两组患者均继续接受当前的治疗。3个月的研究期内试验组患者行洁治和根面清创术,而对照组则接受口腔卫生指导。试验组和对照组患者的平均年龄为50.66±7.70岁

Diabetes:恩格列净降低2型糖尿病患者肾葡萄糖转运效果佳

2017年7月,发表在《Diabetes》的一项由美国科学家进行的研究考察了健康个体和2型糖尿病患者中恩格列净和肾葡萄糖转运的动力学。

Lancet Diabetes Endo:机器学习技术解锁2型糖尿病患者减肥的好处

最新,发表于《柳叶刀》杂志上的文章表示,对于大部分2型糖尿病患者而言,减肥可以减少长期的心血管疾病风险,降低死亡率。但是对于少部分2型糖尿病患者而言,大幅减重会导致更加糟糕的结果。 在此次研究中,85%的研究样本显着,减重可以减少心血管死亡率和发病率。研究人员表示: “我们的分析表明,机器学习因果推论的最新进展可以增加临床相关研究的数量,作为研究人员和数据科学家,我们总是担心整体研究结果可能掩

Intern Med:牙周治疗能降低心血管疾病的发生率

牙周病患者更容易患心血管疾病(CVD)。糖尿病,尤其是严重牙周炎患者,会增加CVD的死亡风险。然而,牙周治疗的结果会因不同的治疗方式而异。本研究旨在探究牙周治疗是否会影响2型糖尿病和牙周炎患者的CVD发生。采用回顾性队列研究设计,数据来自台湾国民健康保险公布的数据集(NHI)。该数据集由随机抽样的新诊断的糖尿病患者组成,他们从1999年到2001年获得保险津贴;年龄小于18岁或1999年以前已经患

Cell stem Cell:华人学者带来“吃不胖”的基因疗法,有望治疗糖尿病

近日,在顶尖学术刊物《细胞》的子刊《Cell Stem Cell》中,来自芝加哥大学的Xiaoyang Wu教授团队发表了他们的一项新发现——将干细胞技术、CRISPR基因编辑技术、与皮肤移植技术相结合,一款基因疗法有望对肥胖症与2型糖尿病这两种常见疾病进行治疗。

Baidu
map
Baidu
map
Baidu
map